A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study-Reference-Cited by-同舟云学术

A randomised phase III study comparing high-dose chemotherapy to conventionally dosed chemotherapy for stage III ovarian cancer: The Finnish Ovarian Cancer (FINOVA) study

Published:2006-09 Issue:14 Volume:42 Page:2196-2199
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Grénman Seija,Wiklund Tom,Jalkanen Jyrki,Kuoppala Tapio,Mäenpää Johanna,Kuronen Arja,Leminen Arto,Puistola Ulla,Vuolo-Merilä Päivi,Salmi Tuula,Vuento Maarit,Yliskoski Merja,Itälä Maija,Helenius Hans,Joensuu Heikki,Lehtovirta Pentti

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference20 articles.

1. Very high-dose chemotherapy with autologous peripheral stem cell support in advanced ovarian cancer;Benedetti-Panici;Eur J Cancer,1995

2. High dose chemotherapy with autologous stem cell support in the treatment of patients with ovarian carcinoma;Shinozuka;Cancer,1999

3. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second-look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results;Bertucci;Bone Marrow Transplant,2000

4. High-dose chemotherapy as a consolidation approach in advanced ovarian cancer: long-term results;Salerno;Bone Marrow Transplant,2001

5. High-dose chemotherapy for ovarian carcinoma: Long-term results from the Solid Tumor Registry of the European Group for Blood and Marrow Transplantation (EBMT);Ledermann;Ann Oncol,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salmonella Control in Swine: A Thoughtful Discussion of the Pre- and Post-Harvest Control Approaches in Industrialized Countries;Animals;2024-03-28

2. Effects of TP regimen combined with intraperitoneal hyperthermic perfusion chemotherapy on immune function, quality of life and prognosis of patients with advanced ovarian cancer;American Journal of Translational Research;2024

3. Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian cancer;Molecular and Clinical Oncology;2021-04-27

4. Hypoxic Isolated Abdominal Perfusion (HAP) chemotherapy for non-operable advanced staged ovarian cancer with peritoneal carcinosis: an experience in 45 platinum-refractory ovarian cancer patients;Indian Journal of Surgical Oncology;2019-04-16

5. Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer;Medical Oncology;2017-04-08